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Abstract
Background With the growing use of vagus nerve stimulation
(VNS) as a treatment for refractory epilepsy, there is a grow-
ing demand for complete removal or replacement of the VNS
system. We evaluate the safety and efficacy of complete re-
moval or replacement of the VNS system and provide an
extensive description of our surgical technique.
Methods We retrospectively reviewed our patient registry for
all VNS surgeries performed between January 2007 (the year
of our first complete removal) and May 2014. In order to
assess patient satisfaction, a written questionnaire was sent
to patients or their caregivers. Additionally, we reviewed all
literature on this topic.
Results The VNS system was completely removed in 22 pa-
tients and completely replaced in 13 patients. There were no
incomplete removals. Revision surgery was complicated by a
small laceration of the jugular vein in two patients and by
vocal cord paralysis in one patient. Seizure frequency was
unaltered or improved after revision surgery. Electrode-
related side effects all improved after revision surgery.
Twenty-one studies reported a total of 131 patients in whom
the VNS system was completely removed. In 95 patients, the
system was subsequently replaced. The most frequently re-
ported side effect was vocal cord paresis, which occurred in
four patients.
Conclusions Complete removal or replacement of the VNS
system including lead and coils is feasible and safe. Although
initial results seem promising, further research and longer
follow-up are needed to assess whether lead replacement
may affect VNS effectiveness.
Keywords Vagus nerve stimulation . Lead . Revision .
Epilepsy . Neuromodulation
Abbreviations
VNS Vagus nerve stimulation
Introduction
Vagus nerve stimulation (VNS) is a neuromodulatory treat-
ment that consists of chronic intermittent electrical stimulation
of the left vagus nerve, delivered by a programmable pulse
generator. This pulse generator is implanted subcutaneously in
the chest wall and connected to a bipolar lead with three heli-
cal coils (two stimulation electrodes and an anchoring tether)
wrapped around the cervical part of the vagus nerve. VNS is
used as an adjunctive treatment for patients with refractory
epilepsy who are not eligible for resective surgery or in whom
resective surgery has failed. The treatment is generally well
tolerated and severe side effects are rare [4, 13, 15, 26].
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Additionally, VNS is approved for refractory depression,
while other indications are being investigated including ad-
vanced heart failure [3, 20, 21].
Well over 85.000 epilepsy patients have been implanted
with a VNS device [7]. With a growing number of implants,
a growing need for removal or replacement of the VNS system
has emerged. Whereas the generator is removed or replaced
routinely, the leads are considered more challenging because
of postoperative scarring close to the larynx, internal jugular
vein, carotid artery, and electrode-nerve complex. In case of
VNS removal it has been advocated to cut the lead a few
centimeters proximal to the coils and leave the rest in situ in
order not to damage the nerve. However, complete removal
may sometimes be necessary, for instance in case of late onset
infection or hardware failure e.g. degradation of the silicone
coating (Fig. 1). Furthermore, complete removal enables un-
restricted use of (high-field) MR imaging techniques that may
be needed in patients that are re-evaluated for epilepsy surgery
[8]. Finally, some patients in whomVNS is ineffective strong-
ly desire complete explantation of the device. The question
therefore arises whether complete removal of VNS lead and
coils is feasible, safe, and whether subsequent replacement
will affect treatment response. In this paper we report our
experience and review the current literature on VNS revision
and removal. We demonstrate that complete removal or re-
placement of the VNS system including lead and coils is




The Medical Ethical Committee of Maastricht University
Medical Center approved this study. We obtained informed
consent to access medical records for research purposes and
retrospectively reviewed our patient registry for all VNS sur-
geries performed at Maastricht University Medical Center, a
tertiary referral hospital, between January 2007 (the year of
our first complete removal) and May 2014. We retrieved the
following data from inpatient and outpatient records: patient
sex, age at revision, interval between implantation and revi-
sion, presenting symptoms, device diagnostics, indications for
removal or replacement, intraoperative findings and hardware
failure, complications, and adverse events.
Patient satisfaction
Awritten questionnaire was sent to all patients or caregivers,
asking them whether seizure frequency and severity were
Bworse^, Bunchanged^, or Bbetter^ compared with preopera-
tively and whether they were satisfied with the result of the
operation. Patients were also asked whether surgery affected
preoperative side effects that occurred with their previous
VNS implant, and whether new adverse events or side effects
occurred after surgery.
Surgical technique (supplemental video)
All procedures but one were performed by the same neurosur-
geon (EC). The operation was performed after administration
of intravenous antibiotics and under strict aseptic conditions
according to our protocol for surgical implants. The generator
was gently moved out of its pocket to disconnect the lead. The
horizontal neck incision was reopened, exposing the lead.
Both fixation booklets were removed and the lead was care-
fully followed through the scar tissue medial to the
sternocleidomastoid muscle towards the neurovascular bundle
containing the carotid, internal jugular vein, and vagus nerve.
As in primary implantations, it is imperative to convert an
aesthetic horizontal incision into a sufficiently large vertical
exposure by mobilizing the platysma on both sides from un-
derlying tissues and keeping it away with a Gelpi retractor
positioned parallel to the medial sternocleidomastoid muscle
border. The omohyoid muscle is mobilized using sharp dis-
section and retracted in cranial (or less frequently caudal) di-
rection using the Gelpi retractor. With gentle longitudinal dis-
section (paralleling the neurovascular structures) using a small
Fig. 1 Intraoperative image: once the generator is moved out of its
pocket, degradation of the silicone coating of the lead is clearly visible.
Note the exact point where the lead has left the silicone coating
(arrowhead) and the trajectory it has subsequently followed (arrow)
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scissor with blunt, curved tips the lead is followed to the he-
lices that may easily be palpated before being exposed. This
also helps to locate the carotid that may remain attached with
its medial border to the laryngeal structures. Likewise, the
internal jugular vein may remain attached with its lateral bor-
der to the inner surface of the sternocleidomastoid muscle,
while the nerve is exposed in between both vessels. The Gelpi
is now carefully repositioned paralleling the internal jugular
vein, and the operating microscope is installed (supplemental
video). The helices are exposed and removed in a cranio-
caudal direction. In case of lead removal, the nerve does not
need to be detached from adhesions underneath, whereas in
case of lead replacement, the nerve needs to be detached very
carefully using scissors while it is gently lifted with a vessel
loop. Excessive (cranio-caudal) traction on the nerve should
be avoided at all times. We have tried microscissors to cut the
coils turn by turn, however, we soon discovered that regular
scissors with straight and blunt, curved tips do a much better
job. Importantly, we have always observed a cleavage plane in
between the nerve on the one end and the helices surrounded by
multiple layers of scar tissue on the other end. This cleavage
plane can be found with surprising ease when the most cranial
helix of the most cranial coil is gently lifted and cut with a small
scissor under microscopic view. Subsequently, the three coils are
removed in a piecemeal fashion, exposing the vagus nerve,
which usually looks surprisingly normal thereafter (Fig. 2), ex-
cept for those rare cases where we observed a kink in the nerve
caused by a suboptimal position of the helices and/or strain relief
loops. In such patients, short segment atrophy of the nerve due to
chronic constriction may be observed (Fig. 3). We never leave a
coil behind, and prefer to position the coils of the new lead in the
exact same position so as to avoid exposure and
devascularization of an unnecessarily long nerve segment. Espe-
cially in case of reimplantation, the surgical field is repeatedly
irrigated with saline solution containing gentamicin. Once all
hardware has been completely removed, reimplanting an entirely
new VNS system is as straightforward as the initial procedure,
and the wound is closed in a regular fashion.
Literature review
We performed a literature search in PubMed, Google Scholar,
and Embase using the keywords Bvagus nerve stimulation^ or
Bvagal nerve stimulation^, or BVNS^, combined with
Bremoval^, Breplacement^, or Brevision^. Only original stud-
ies written in English, describing removal or replacement of
the VNS system including the leads, were included.Whenever
it was unclear whether the lead was completely removed, the




Between January 2007 and July 2014, 35 patients underwent
VNS removal or revision surgery, including 25 adults (mean
Fig. 2 Intraoperative images
before (a, b) and after (c) removal
of the helices and finally with the
new lead in place (d). A blue
vessel loop surrounds the vagus
nerve (c, carotid artery; h, helices;
j, internal jugular vein)
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age at surgery 34 years, range, 18–62 years) and ten children
(mean age at surgery 16 years, range 11 to 17 years). All
revisions (removal with or without replacement) were first
revisions and the mean interval between initial implantation
and revision was 7 years (range, 1–17 years).
VNS removal
In 19 patients, the VNS system was completely removed. In
three additional patients, generator and proximal part of the
lead had been removed in another hospital, leaving the distal
part of the lead and helices wrapped around the nerve to be
removed at our center. All attempted removals were complete,
and there were no incomplete removals during the study pe-
riod in our institution. The interval between lead implantation
and removal was on average 7 years (range, 1–14 years). All
patients requested removal because VNS was ineffective. Ad-
ditionally, five patients required high-field MR imaging, two
patients experienced paresthesias over a damaged lead, and
one patient experienced discomfort because of a subcutane-
ously mobile generator. In one patient, an 11-year-old boy, full
VNS replacement was planned but abandoned because the
nerve appeared to be severely damaged and atrophied due to
chronic constriction as a consequence of a suboptimal position
of the helices and/or strain relief loops. In two patients, a small
laceration of the internal jugular vein occurred, which was
easily repaired with a polypropylene 6/0 suture.
VNS replacement
In 13 patients, the VNS system was completely removed and
replaced on average 8 years (range, 3–17 years) after initial
implantation. Nine patients presented with an increasing sei-
zure frequency and/or seizure severity. In two patients, the
generator was routinely replaced as the battery was near end
of life, however, as we observed a breach in the silicone insu-
lation of the lead (Fig. 1), we decided to replace the entire
system. One patient presented with new unexplained side ef-
fects (cough and dyspnea) suggesting a dysfunctional lead.
Although nothing abnormal was observed intraoperatively,
the complaints disappeared after lead replacement. One pa-
tient presented with an obvious lead fracture. One patient
complained of hoarseness and dysphonia immediately after
surgery and was diagnosed with left vocal cord paralysis. At
3-year follow-up, the patient merely experienced stimulation-
induced dysphonia, while during the stimulation-free interval,
his voice was normal.
Patient satisfaction
At the time of follow-up, two patients were deceased. Sixteen
of the remaining 33 patients (48 %) completed and returned
the questionnaire, including 11 removals and five replace-
ments. Regarding seizure frequency and severity, three of five
patients (60 %) with a replacement reported less frequent and
less severe seizures, whereas the other two (40 %) reported no
obvious change. Among 11 patients in whom the VNS system
was completely removed, two (18 %) reported less frequent
seizures and nine (82 %) reported no obvious change, while
seizure severity was unaffected in all. Those suffering from
electrode-related side effects prior to removal (n=3) reported
no more side effects after removal.
Literature review
We identified seven studies [1, 9, 11, 17–19, 30] and five case
reports [12, 23, 27–29] focusing on lead removal or replace-
ment. Additionally, nine studies described lead removal or
Fig. 3 Intraoperative image
demonstrating short segment
atrophy of the vagus nerve as a
result of chronic constriction
caused by suboptimal position of
the helices and/or strain relief
loops. Impressions caused by
three individual helices (especial-
ly the middle one) are clearly
visible (arrows). The instrument
is holding scar tissue (s) attached
to and surrounding the vagus
nerve
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replacement as part of a broader report on VNS treatment
[2, 6, 10, 14, 16, 22, 24, 25, 31]. The included studies are
summarized in Table 1. In 131 patients (including 52 children)
the lead was completely removed and in 95 of them the lead
was replaced. The interval between implantation and removal
or replacement ranged between 1 month and 11 years. The
main reasons for removal were lack of response and the oc-
currence of adverse effects, such as increased seizure frequen-
cy, unpleasant sensation, or impaired swallowing. Main rea-
sons for replacement were device malfunction and infection.
Complete removal or replacement were complicated by vocal
cord paresis (n=4), which resolved in three patients [19, 22,
29], but was permanent in one patient [19].
Discussion
VNS is an adjunctive therapy for refractory epilepsy.
The first-generation VNS leads (301, 302) have proven
to degrade over time, which results in tears in the sili-
cone coating (Fig. 1) that may lead to electrical failure
(high impedance) or stimulation related side effects, or
even in complete fracture as seen on X-ray examination.
Patients that benefit from VNS carrying a first-
generation lead are at risk for lead fracture and may
require lead revision at some point in their lives. More-
over, with increasing use of VNS for different indica-
tions, the demand for removal or replacement will likely
increase. With this paper we demonstrate that a com-
plete revision of any VNS device including the leads
is feasible, safe, and effective.
In our experience, revision surgery takes about 30
(removal) to 60 (replacement) minutes longer than an
initial implantation (which typically takes approximately
45 min), as careful dissection of fibrous scar tissue sur-
rounding the neurovascular bundle under microscopic
magnification is needed. Our first few revisions took
significantly longer, however, operative time decreases
with increasing lead revision experience [1, 9]. A long
interval between implantation and revision does not im-
pede complete removal [9, 12], as we have successfully
removed leads that had been implanted more than ten
years ago. Of note, we have always observed a cleavage
plane in between the nerve on the one end and the
helices surrounded by multiple layers of scar tissue on
the other end. Similarly, a patient’s age does not affect
the feasibility of lead revision [19].
The most common adverse event associated with lead
revision surgery is vocal cord paresis, which has been
reported in five cases including one of our patients
(4/131 (3.0 %) in the literature as compared to 1/35
(2.8 %) in our series) [19, 22, 29]. The incidence there-
fore seems to be slightly higher than after initial
implantation, where vocal cord paresis has been report-
ed in approximately 1 % of patients [5]. Vocal cord
paresis results from injury to the fibers of the recurrent
laryngeal nerve as a result of direct surgical trauma,
disruption of the delicate vascularization, and/or second-
ary inflammation in the nerve’s surroundings, in which
case paresis may appear several weeks after revision
[22, 29]. In most patients, symptoms subsided complete-
ly, even though vocal cord paresis remained in two of
them.
Both in our series and in the literature, lead replace-
ment is usually performed because of infection or de-
vice malfunction, the former being reported in 3–6 % of
patients after initial implantation [5]. Lead salvage by
prolonged antibiotic therapy with or without removing
the generator may be attempted [31], but persistent in-
fection will necessitate removing all hardware. Lead
malfunction usually results from tears in the silicone
coating (Fig. 1) or even a complete fracture that occurs
either spontaneously or after a trauma. In our series, we
observed eight lead failures. In the near future, we ex-
pect to see more patients with a first-generation lead
(301, 302) requiring lead replacement, however, it is
hoped the second-generation leads (303, 304) will prove
to be more fatigue-resistant with fever patients requiring
revisions, even long term.
Finally, with regard to the efficacy of a replaced
VNS system, Dlouhy et al. reported that the replaced
VNS system was as effective as the initial one in 15
out of 16 cases they had operated [9]. Waseem et al.
reported that nine out of ten patients reported an equal
or improved clinical response compared with their initial
VNS system, and none of them reported a worse quality
of life [30]. The number of anti-epileptic drugs was
unaltered in the vast majority of patients [30]. The an-
swers to our questionnaire seem to confirm these find-
ings. However, they are self-reported and therefore sub-
ject to a placebo effect. In order to prove that VNS
revision including lead replacement does not negatively
influence VNS effectiveness, more research including
meticulous analysis from long-term neurological
follow-up data is needed.
Conclusions
Our institutional series and overview of the literature confirms
that complete removal of all VNS hardware (including the
lead and three helical coils) is technically feasible and safe.
Although initial results seem promising, further research and
longer follow-up are needed to assess whether lead replace-
ment may affect VNS effectiveness. The fact that VNS can be
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considered fully reversible makes it an even more attractive
treatment option.
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